Personalized Medicine: A Policy Discussion on the Next Health Frontier

In an era of personalization -- where music apps filter songs based on listener preferences and online ads populated based on user search history -- healthcare is the next frontier. Scientific advances are transforming healthcare and ushering in a new era of personalized – or precision – medicine. This approach makes it possible to account for each patient’s genetics, health history and lifestyle as researchers develop and doctors prescribe individualized treatments. On October 22nd, The Hill convened a discussion on the impact of this emerging field, the challenges to its progress, and how the Precision Medicine Initiative fits into the complex personalized medicine ecosystem.



WATCH THE FULL EVENT VIDEO HERE

Featured speakers:

Steven D. Averbuch, M.D., Vice President, Development, Oncology & Pharmacodiagnostics, Bristol-Myers Squibb
Alan Balch, Ph.D., CEO, Patient Advocate Foundation & National Patient Advocate Foundation
John J. Castellani, President & CEO, PhRMA
Kathy Hudson, Ph.D., Deputy Director for Science, Outreach and Policy, National Institutes of Health [NIH]
Elizabeth Mansfield, Ph.D., Director of Personalized Medicine in the Office of In Vitro Diagnos​tics Device Evaluation & Safety, Center for Devices and Radiological Health, Food & Drug Administration [FDA]
Amy Miller, Ph.D., Executive Vice President, Personalized Medicine Coalition

Hosted & moderated by:

Bob Cusack, Editor-in-Chief, The Hill
Sarah Ferris, Staff Writer, The Hill


Share your thoughts with @thehillevents using #PersonalizedMedicine

Sponsored by: